anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

208,381-208,440 of 319,975

filter-aware
30
The table compares KT-474 (Part C) at Day 28 and 42 against external benchmarks at Week 4. Includes extensive footnote citations.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
31
The footer explicitly notes the absence of Serious Adverse Events (SAEs), infections, or events leading to discontinuation.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
32
Data presented as mean change from baseline with 90% CI. Includes table of mean values for delta QTc and absolute QTc.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
33
The slide uses color-coded text (orange) to emphasize key positive outcomes within the bullet points.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
34
Kymera | Investor Presentation Deck | 60 slidesKymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
35
The diagram illustrates the signaling pathways (TLR, IL-1R, B Cell Receptor) and the specific points of intervention (red asterisks) for the therapy.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
36
The slide presents two charts: a tumor growth inhibition curve and a PK/PD correlation chart showing drug concentration vs. target degradation over time.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
37
The slide outlines a clinical trial design using a dose-escalation process leading to MTD/RP2D expansion cohorts.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
38
Data presented for Cycle 1; DL4 shows mean values for n=2 patients.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
39
Includes a disclaimer/footnote regarding patient population and MYD88 mutation status.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
40
The slide uses a split-layout: left side focuses on clinical data (PK/PD/Safety), right side focuses on strategic positioning and clinical development plan.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
41
Kymera | Investor Presentation Deck | 60 slidesKymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
42
Includes a table of prevalence/incidence for specific oncology indications and a biological pathway diagram.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
43
The slide presents two distinct charts: a tumor volume growth curve and a PK/PD concentration-time profile.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
44
The slide outlines a standard oncology clinical trial design (3+3 or similar dose escalation) followed by cohort expansion.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
45
Clinical trial safety data table showing patient counts and percentages for specific adverse events.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
46
Includes a line chart for PK profiles and a table for PK parameters (Cmax, AUClast, Vd, CL, t1/2).Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
47
The slide presents clinical trial results for KT-333, comparing degradation percentages across three dose levels (DL1, DL2, DL3) over two cycles.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
48
Includes bar charts for SAA/CRP reduction, a longitudinal line chart for biomarker changes, and a scatter plot showing correlation between STAT3 and SOCS3 changes.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
49
DL1-3 refers to dose levels 1-3. PK = Pharmacokinetics, PD = Pharmacodynamics, DLT = Dose-Limiting Toxicity, SAE = Serious Adverse Event.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
50
Abstract background image, likely a placeholder or thematic divider.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
51
Includes a DepMap CRISPR sensitivity plot and a biological pathway diagram illustrating the feedback loop.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
52
Includes a biological pathway diagram and Western blot data comparing a degrader (KT-253) to an inhibitor (DS-3032).Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
53
Includes a table comparing clinical stage and potency metrics (IC50, DC50) across multiple competitors.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
54
Data presented as tumor volume growth curves and Kaplan-Meier survival plots.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
55
The slide presents five bar charts showing protein levels across different dosing regimens and time points.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
56
Shows two distinct experiments: DFAM-6855 (Whole Blood) and MOLM-13 (Tumor Volume).Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
57
The slide title mentions KT-333, but the content refers to KT-253 throughout; this is likely a typo in the source deck.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
58
The slide uses a split-layout to contrast mechanism benefits (left) with strategic market opportunity (right).Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
59
Kymera | Investor Presentation Deck | 60 slidesKymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
60
The image shows the Kymera Therapeutics team at their Nasdaq listing event.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
01
Slide 1
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Attention1 hit
02
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Attention1 hit
03
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Attention1 hit
04
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Attention1 hit
05
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Need1 hit
06
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Need1 hit
07
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Need1 hit
08
The slide uses a background image of lemons on a tree, consistent with the company's agricultural focus.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Need1 hit
09
The slide uses a two-row circular image layout to represent chronological events.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Need1 hit
10
The slide uses a dual-row timeline format with circular imagery for each milestone.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Need1 hit
11
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · NeedLoop · Quick Win Big Bet1 hit
12
The slide uses a horizontal flow diagram to connect business segments to their respective financial or operational outcomes.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · NeedLoop · Quick Win Big Bet1 hit
13
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · NeedLoop · Quick Win Big Bet1 hit
14
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · NeedLoop · Quick Win Big Bet1 hit
15
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · NeedLoop · Quick Win Big Bet1 hit
16
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · NeedLoop · Quick Win Big Bet1 hit
17
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Satisfaction1 hit
18
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Satisfaction1 hit
19
The chart shows five distinct growth drivers: Items Completed, Grower Partner Growth, Agency Growth, Farm Management Services Growth, and New Chile Packing House.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Satisfaction1 hit
20
Uses a before-after-bridge structure to show growth from 3,000 to 5,000 acres.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
21
Uses a before-after-bridge structure to show how operational changes lead to financial outcomes.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
22
The slide uses a simple equation structure (Current State + Fallowing Program = Future EBITDA Goal).Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
23
Uses a simple equation-style layout (Current + Goal = Result).Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Satisfaction1 hit
24
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Satisfaction1 hit
25
Uses a before-after-bridge structure to show the impact of a $25M investment.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Satisfaction1 hit
26
The slide uses a simple additive logic (sum of parts equals total) to present the growth target.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Satisfaction1 hit
27
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Satisfaction1 hit
28
The slide highlights global reach and scale, emphasizing 365/24/7 availability.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Satisfaction1 hit
29
The slide uses a process flow diagram to map business models to specific supply chain activities.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Satisfaction1 hit